Chronic or intermittent sleep disorders including narcolepsy, REM behavior disorder, sleep apnea, and insomnia afflict nearly 50-70 million people in the United States. Yet the neural mechanisms controlling both normal sleep and its pathologies remain poorly understood. Considerable evidence indicates that mesopontine cholinergic neurons and other neurons at the mesopontine junction are critical for this control and that their disregulation is involved in narcolepsy, REM behavior disorder, Parkinson's disease, supranuclear palsy and depression. The long term goal of this project is to understand the mechanisms regulating activity of these neurons and their functions in regulating sleep and sleep pathologies. Compelling evidence indicates that disruption of the Hypocretin/Orexin (Hcrt/Orx) peptide system results in narcolepsy - a sleep disorder characterized by excessive daytime sleepiness, sleep fragmentation and the intrusion of rapid eye movement sleep behaviors into wakefulness. Building on the findings from previous funding periods, which showed that mesopontine cholinergic neurons and dorsal raphe serotonergic neurons are important targets of these peptides, we will continue to investigate the general hypothesis that Hcrt/Orx peptides regulate both the short- term and long-term excitability of these neurons. We will explicitly test the hypothesis that cholinergic transmission resulting from mesopontine cholinergic neurons contribute the disruptions of waking and sleep in narcoleptic mice and that they promote the entrance into cataplexy but that their activity contributes little to regulating te duration of cataplectic attacks. To do so we will 1) identify the mechanisms underlying a new class of post-synaptic orexin actions post-spike afterhyperpolarization in mesopontine cholinergic neurons and dorsal raphe serotonergic neurons. 2) Explore the impact of the major orexin actions on firing pattern and encoding of inputs by mesopontine cholinergic neurons and dorsal raphe serotonergic neurons. 3) determine whether selective excitation and inhibition of mesopontine cholinergic neurons can regulate arousal and sleep in normal and narcoleptic mice and whether these neurons can trigger cataplexy in narcoleptic mice. These experiments will use whole-cell patch clamp recording, calcium imaging and dynamic clamp methods in brain slices from normal and orexin receptor knockout mice and will utilize optogenetic stimulation methods in normal and narcoleptic mice. Collectively, these results will advance our understanding of the molecular and cellular mechanisms underlying sleep regulation and its pathology.
Sleep disorders such as narcolepsy, REM behavior disorder, sleep apnea, and insomnia afflict 50-70 million people in the United States. Yet the neural mechanisms controlling both normal sleep and its pathologies remain poorly understood. The proposed research will advance our understanding of these mechanisms by elucidating the actions of hypocretin/orexin neuropeptides on brain circuits thought to be critical for regulating arousal and sleep. We will also selectively stimulate and inhibit one of these circuits in normal and narcoleptic mice to gain a better understanding of how the loss of hypocretin/orexin signaling leads to the sleep disorder narcolepsy. In addition to contributing to a better understanding of how sleep and waking are regulated by the brain, clarifying these mechanisms will help identify neural circuits that might be ultimately exploited for therapeutic interventionsin these disorders.
|Ishibashi, Masaru; Gumenchuk, Iryna; Miyazaki, Kenichi et al. (2016) Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization. J Neurosci 36:10097-115|
|Ishibashi, Masaru; Gumenchuk, Iryna; Kang, Bryan et al. (2015) Orexin Receptor Activation Generates Gamma Band Input to Cholinergic and Serotonergic Arousal System Neurons and Drives an Intrinsic Ca(2+)-Dependent Resonance in LDT and PPT Cholinergic Neurons. Front Neurol 6:120|
|Leonard, C S; Kukkonen, J P (2014) Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 171:294-313|
|Kukkonen, J P; Leonard, C S (2014) Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 171:314-31|
|Christensen, Mark H; Ishibashi, Masaru; Nielsen, Michael L et al. (2014) Age-related changes in nicotine response of cholinergic and non-cholinergic laterodorsal tegmental neurons: implications for the heightened adolescent susceptibility to nicotine addiction. Neuropharmacology 85:263-83|
|Kohlmeier, Kristi A; Tyler, Christopher J; Kalogiannis, Mike et al. (2013) Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci 7:246|
|Kohlmeier, Kristi A; Ishibashi, Masaru; Wess, Jurgen et al. (2012) Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus. J Neurophysiol 108:2751-66|
|Kalogiannis, Mike; Hsu, Emily; Willie, Jon T et al. (2011) Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice. PLoS One 6:e18697|
|Kalogiannis, M; Grupke, S L; Potter, P E et al. (2010) Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons. Eur J Neurosci 32:130-42|
|Konduri, G Ganesh; Vohr, Betty; Robertson, Charlene et al. (2007) Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 150:235-40, 240.e1|